Slán Medicinal Holdings

Slán Medicinal Holdings is an Irish biopharmaceutical company focused on the research and development of pharmaceutical-grade medicines derived from phytocannabinoids. Operating primarily through its research arm, GreenLight Medicines, the company targets a variety of clinical indications including epilepsy, multiple sclerosis, and chronic pain. Their approach involves isolating and standardizing specific compounds from the cannabis plant to create consistent, evidence-based therapeutic treatments. The company emphasizes rigorous clinical testing and maintains extensive academic collaborations to validate the efficacy of its pipeline. Slán Medicinal Holdings aims to bridge the gap between traditional herbal medicine and modern clinical pharmacology in the cannabinoid space.